Testing, Inspection Deviations Land French Sanofi Pasteur Plant Form 483

Drug GMP Report
One of Sanofi Pasteur’s French manufacturing facilities received an FDA Form 483 for straying from agency regulations on investigating discrepancies and testing samples of supplied materials.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $135.00